Two Chemotherapy Regimens Compared With Observation in Treating Patients With Completely Resected Pancreatic Cancer
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- David Goldstein, MD
Institute of Oncology at Prince of Wales Hospital
- John P. Neoptolemos, MD
Royal Liverpool University Hospital
Study Chair - Malcolm J. Moore, MD
Princess Margaret Hospital, Canada
Study Chair - R. Padbury
Flinders Medical Centre
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
27 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Institute of Oncology at Prince of Wales Hospital
Randwick, New South Wales, Australia
- Flinders Medical Centre
Bedford Park, South Australia, Australia
- Cross Cancer Institute at University of Alberta
Edmonton, Alberta, Canada
- British Columbia Cancer Agency - Centre for the Southern Interior
Kelowna, British Columbia, Canada
- British Columbia Cancer Agency - Vancouver Island Centre
Victoria, British Columbia, Canada
- Cancercare Manitoba
Winnipeg, Manitoba, Canada
- Nova Scotia Cancer Centre
Halifax, Nova Scotia, Canada
- Cancer Centre of Southeastern Ontario at Kingston General Hospital
Kingston, Ontario, Canada
- Cancer Research Institute at Queen'S University
Kingston, Ontario, Canada
- London Regional Cancer Program at London Health Sciences Centre
London, Ontario, Canada
- Ottawa Hospital Regional Cancer Centre - General Campus
Ottawa, Ontario, Canada
- Edmond Odette Cancer Centre at Sunnybrook
Toronto, Ontario, Canada
- Princess Margaret Hospital
Toronto, Ontario, Canada
- St. Joseph'S Health Centre - Toronto
Toronto, Ontario, Canada
- Hopital Charles Lemoyne
Greenfield Park, Quebec, Canada
- Mcgill Cancer Centre at Mcgill University
Montreal, Quebec, Canada
- Institute for Clinical and Experimental Medicine
Preha 4, Czechia
- Tampere University Hospital
Tampere, Finland
- Hopital Tenon
Paris, France
- Universitaets-Kinderklinik Heidelberg
Heidelberg, Germany
- Agia Olga Hospital
Athens, Greece
- Petz Aladar County Hospital
Gydr, Hungary
- Policlinico Borgo Roma
Verona, Italy
- Kyoto University Hospital
Kyoto, Kyoto, Japan
- Uppsala University Hospital
Uppsala, Sweden
- Inselspital Bern
Bern, Switzerland
- Royal Liverpool University Hospital
Liverpool, England, United Kingdom
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Jul 2001
- Primary completion
- 30 Apr 2008
- Completion
- 30 Sept 2010
- Last update posted
- 18 Dec 2013
- Registered enrollment
- 1,030
- Registry id
- NCT00058201
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.